Sommerlatte, Sabine http://orcid.org/0000-0001-6239-4349
Lugnier, Celine
Schoffer, Olaf
Jahn, Patrick
Kraeft, Anna-Lena
Kourti, Eleni
Michl, Patrick
Reinacher-Schick, Anke
Schmitt, Jochen
Birkner, Thomas
Schildmann, Jan
Herpertz, Stephan
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (01KI20521A-C, 01KI20521A-C, 01KI20521A-C, 01KI20521A-C, 01KI20521A-C, 01KI20521A-C, 01KI20521A-C, 01KI20521A-C, 01KI20521A-C)
Martin-Luther-Universität Halle-Wittenberg
Article History
Received: 4 November 2022
Accepted: 7 January 2023
First Online: 26 January 2023
Declarations
:
: Jochen Schmitt reports institutional grants for investigator-initiated research from the German GBA, the BMG, BMBF, EU, Federal State of Saxony, Novartis, Sanofi, ALK, and Pfizer. He also participated in advisory board meetings as a paid consultant for Sanofi, Lilly, and ALK. Patrick Jahn reports institutional grants for investigator-initiated research from the BMBF, EU, German Cancer Society and Federal State of Saxony-Anhalt. He is board member of KOK.
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted in January 2021 by the Ethics Committee of the medical faculty of Martin Luther University Halle-Wittenberg (reference number: 2021–001).
: Informed consent was obtained from all participants via the online survey. Participation was anonymous. The response and electronic sending are considered as consent to participation.